Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden) General Information

Description

Operator of an R&D (research and development) operations company based in Stockholm, Sweden. The company operates research on pre-clinical development and biosimilar candidate drugs.

Contact Information

Formerly Known As
BIIB801
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Karolinska Institute
  • Stockholm
  • Sweden
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Alvotech
Corporate Office
  • Karolinska Institute
  • Stockholm
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden)‘s full profile, request access.

Request a free trial

Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden)‘s full profile, request access.

Request a free trial

Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden) FAQs

  • Where is Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden) headquartered?

    Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden) is headquartered in Stockholm, Sweden.

  • What industry is Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden) in?

    Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden)’s primary industry is Drug Delivery.

  • Is Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden) a private or public company?

    Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden) is a Private company.

  • What is the current valuation of Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden)?

    The current valuation of Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden) is .

  • What is Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden)’s current revenue?

    The current revenue for Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden) is .

  • Who are Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden)’s investors?

    Xbrane Biopharma has invested in Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden).

  • When was Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden) acquired?

    Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden) was acquired on 04-Jun-2025.

  • Who acquired Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden)?

    Xbrane Biopharma (R&D Operations and Biosimilar Candidate XB003 in Stockholm, Sweden) was acquired by Alvotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process